Stocks and InvestingStocks and Investing
Thu, October 26, 2023
Wed, October 25, 2023
Tue, October 24, 2023

Josh Schimmer Initiated (XENE) at Buy on, Oct 24th, 2023


Published on 2024-10-28 07:02:50 - WOPRAI, Josh Schimmer
  Print publication without navigation


Josh Schimmer of Cantor Fitzgerald, Initiated "Xenon Pharmaceuticals Inc." (XENE) at Buy on, Oct 24th, 2023.

Josh has made no other calls on XENE in the last 4 months.



There are 4 other peers that have a rating on XENE. Out of the 4 peers that are also analyzing XENE, 0 agree with Josh's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Josh


  • Brian Abrahams of "RBC Capital" Reiterated at Buy and Held Target at $51 on, Friday, September 22nd, 2023
  • Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $58 on, Tuesday, August 22nd, 2023
  • Laura Chico of "Wedbush" Reiterated at Buy and Held Target at $47 on, Thursday, August 10th, 2023
  • Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $50 on, Thursday, August 10th, 2023